Serum Institute of India has benefitted from sales of its “Covishield” branded vaccines during the COVID-19 pandemic, and since then, has also invested in other vaccines for malaria ...

As part of its capacity-building engagements with friendly foreign nations of the Indian Ocean Region (IOR), India gifted two ...

India strengthens maritime security in Mozambique through capacity-building initiatives, including gifting vessels and ...

As part of its capacity-building engagements with friendly foreign nations of the Indian Ocean Region IOR India has gifted two water-jet propelled Fast Inter ...

The Commission reportedly concluded, stating that the transaction does not cause competitive concerns in the region due to ...

Controversy followed close on the heels of a recent study on the long-term safety of Covaxin, the Covid-19 vaccine developed by Bharat Biotech in collaboration ...

Prime Minister Narendra Modi has launched U-WIN, a groundbreaking online platform designed to streamline the vaccination process for pregnant women and children across India. This initiative aims ...

Disclaimer: All names, characters and incidents mentioned in this column, however believable, are entirely satirical. No identification with actual persons (living or deceased), places, organisations ...

In August 2021, Serum purchased 50% stake in the JV SCHOTT Kaisha from former co-owners Kairus Dadachanji and Shapoor Mistry ...

SII is celebrated for its crucial role in global healthcare, particularly during the COVID-19 pandemic, producing affordable vaccines like Covishield. This deal solidifies his footprint in the ...

"Mere Covishield ke paise se Student of the Year 3 banayenge (They will make Student of the Year 3 with the money I paid for my Covishield vaccine)," quipped comedian Uddhav Parab on X. Another user, ...

1) Adar Poonawalla is the CEO of Serum Institute of India, the world’s largest vaccine-producing company in terms of volume, which produced Covishield in India. He is also the Chairman of ...